Olon USA

Who we are: On June 9, 2017, Olon S.p.A., a leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) and Generics supplier, announced the acquisition of Ricerca Biosciences’ Chemical Division of the contract research (CRO) and CDMO based in Concord, Ohio, USA. This acquisition strengthens the service offering of Olon for the pharmaceutical and biotech industry and benefits Ricerca Biosciences' customer base by providing large-scale manufacturing capabilities in Europe. Olon USA is a US-based CDMO supporting the development and manufacture of APIs and performance materials in support clinical supply, market development and commercial distribution. Olon USA’s extensive process/synthetic chemistry, analytical chemistry and engineering expertise provides a synergy that excels at first-time scale-ups and subsequent development of safe, reliable, robust and cost-effective manufacturing processes. For more than 25 years, Olon USA has a record of on-time delivery and quality, providing comprehensive support and problem solving for successful development, scale-up and process-optimized manufacture of pharmaceutical ingredients. Company Details Website: http://www.olon-usa.com Location: Concord, OH Florham Park, NJ